Back to Search
Start Over
Advancing drug discovery for glomerulopathies using stem-cell-derived kidney models.
- Source :
-
Trends in pharmacological sciences [Trends Pharmacol Sci] 2023 Apr; Vol. 44 (4), pp. 204-207. Date of Electronic Publication: 2022 Dec 22. - Publication Year :
- 2023
-
Abstract
- Chronic kidney disease (CKD) is an epidemic that affects millions worldwide. The glomerulus, a specialized unit of the nephron, is highly susceptible to injury. Human induced pluripotent stem cells (iPSCs) have emerged as an attractive resource for modeling kidney disease and therapeutic discovery.<br />Competing Interests: Declaration of interests None declared by the authors.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-3735
- Volume :
- 44
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Trends in pharmacological sciences
- Publication Type :
- Academic Journal
- Accession number :
- 36566132
- Full Text :
- https://doi.org/10.1016/j.tips.2022.12.001